Back
Day Range
$11.89
$12.14
52-Week Range
$6.69
$15.42
Volume
1,509,954
50D / 200D Avg
$13.66
/
$10.91
Prev Close
$11.83
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 52.1 | 14.0 |
| P/B | — | 2.4 |
| ROE % | — | 11.4 |
| Net Margin % | 2.4 | 10.1 |
| Rev Growth 5Y % | 9.6 | 7.0 |
| D/E | — | 0.5 |
Key Takeaways
Revenue grew 9.58% annually over 5 years — modest growth
Generating 269.93M in free cash flow
P/E of 52.05 — premium valuation
Cash machine — converts 374.60% of earnings into free cash flow
Capital efficient — spends only 2.32% of revenue on capex
Interest coverage of 1.75× — tight debt servicing
Growth
Revenue Growth (5Y)
9.58%
Revenue (1Y)8.05%
Earnings (1Y)N/A
FCF Growth (3Y)-1.18%
Quality
Return on Equity
N/A
ROIC11.90%
Net Margin2.39%
Op. Margin14.02%
Safety
Debt / Equity
N/A
Current Ratio2.17
Interest Coverage1.75
Valuation
P/E Ratio
52.05
P/B RatioN/A
EV/EBITDA14.60
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.05% | Revenue Growth (3Y) | 12.30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.58% | Earnings Growth (5Y) | 61.38% |
| Profitability | |||
| Revenue (TTM) | 3.02B | Net Income (TTM) | 72.06M |
| ROE | N/A | ROA | 1.96% |
| Gross Margin | 37.63% | Operating Margin | 14.02% |
| Net Margin | 2.39% | Free Cash Flow (TTM) | 269.93M |
| ROIC | 11.90% | FCF Growth (3Y) | -1.18% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.17 |
| Interest Coverage | 1.75 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 52.05 | P/B Ratio | N/A |
| P/S Ratio | 1.24 | PEG Ratio | -0.34 |
| EV/EBITDA | 14.60 | Dividend Yield | 0.00% |
| Market Cap | 3.75B | Enterprise Value | 6.18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.02B | 2.79B | 2.39B | 2.21B | 2.09B |
| Net Income | 72.06M | -116.89M | -83.99M | -129.99M | 10.62M |
| EPS (Diluted) | 0.22 | -0.38 | -0.48 | -0.86 | 0.07 |
| Gross Profit | 1.14B | 1.02B | 863.87M | 791.46M | 768.97M |
| Operating Income | 423.09M | 249.33M | 204.37M | -94.93M | 152.72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.68B | 3.50B | 3.47B | 3.80B | 3.94B |
| Total Liabilities | 3.67B | 3.55B | 3.41B | 3.59B | 3.57B |
| Shareholders' Equity | -70.79M | -109.27M | 19.78M | 298.42M | 360.34M |
| Total Debt | 2.74B | 2.59B | 2.75B | 2.85B | 2.88B |
| Cash & Equivalents | 310.87M | 110.55M | 91.54M | 25.98M | 247.79M |
| Current Assets | 1.91B | 1.59B | 1.38B | 1.41B | 1.52B |
| Current Liabilities | 881.63M | 1.13B | 846.60M | 752.80M | 677.24M |